Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

IART - INTEGRA LIFESCIENCES HOLDINGS CORP


IEX Last Trade
22.335
-0.035   -0.157%

Share volume: 12,380
Last Updated: Fri 27 Dec 2024 08:30:11 PM CET
Surgical and Medical Instrument Manufacturing : -0.06%

PREVIOUS CLOSE
CHG
CHG%

$22.37
-0.04
-0.16%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
13%
Profitability 17%
Dept financing 25%
Liquidity 39%
Performance 0%
Company vs Stock growth
vs
Performance
5 Days
3.13%
1 Month
-7.50%
3 Months
27.03%
6 Months
-21.04%
1 Year
-48.27%
2 Year
-59.57%
Key data
Stock price
$22.34
P/E Ratio 
66.73
DAY RANGE
$22.10 - $22.65
EPS 
$0.30
52 WEEK RANGE
$17.22 - $45.42
52 WEEK CHANGE
-$47.88
MARKET CAP 
1.578 B
YIELD 
N/A
SHARES OUTSTANDING 
77.582 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/30/2024
BETA 
0.87
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$619,048
AVERAGE 30 VOLUME 
$538,173
Company detail
CEO: Jan D. de Witte
Region: US
Website: integralife.com
Employees: 3,720
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, surgical headlamps and instrumentation.

Recent news